nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinastine—ABCB1—Topotecan—cervical cancer	0.528	0.625	CbGbCtD
Epinastine—CYP3A4—Topotecan—cervical cancer	0.316	0.375	CbGbCtD
Epinastine—HTR7—epithelium—cervical cancer	0.00477	0.0388	CbGeAlD
Epinastine—ADRA1A—epithelium—cervical cancer	0.0046	0.0374	CbGeAlD
Epinastine—HTR7—renal system—cervical cancer	0.00442	0.036	CbGeAlD
Epinastine—ADRA1A—renal system—cervical cancer	0.00427	0.0347	CbGeAlD
Epinastine—HRH2—lymph node—cervical cancer	0.00408	0.0331	CbGeAlD
Epinastine—HRH1—epithelium—cervical cancer	0.00356	0.0289	CbGeAlD
Epinastine—HTR7—female reproductive system—cervical cancer	0.00354	0.0288	CbGeAlD
Epinastine—HRH1—uterine cervix—cervical cancer	0.00353	0.0287	CbGeAlD
Epinastine—ADRA2A—uterine cervix—cervical cancer	0.00347	0.0282	CbGeAlD
Epinastine—CYP2B6—renal system—cervical cancer	0.00338	0.0275	CbGeAlD
Epinastine—HRH1—decidua—cervical cancer	0.00336	0.0273	CbGeAlD
Epinastine—ADRA2A—decidua—cervical cancer	0.0033	0.0269	CbGeAlD
Epinastine—HRH1—endometrium—cervical cancer	0.00319	0.026	CbGeAlD
Epinastine—ADRA2A—endometrium—cervical cancer	0.00314	0.0255	CbGeAlD
Epinastine—HRH1—mammalian vulva—cervical cancer	0.00309	0.0251	CbGeAlD
Epinastine—ADRA2A—mammalian vulva—cervical cancer	0.00303	0.0247	CbGeAlD
Epinastine—HTR2A—epithelium—cervical cancer	0.00297	0.0242	CbGeAlD
Epinastine—ADRA2A—uterus—cervical cancer	0.00289	0.0235	CbGeAlD
Epinastine—HTR2A—renal system—cervical cancer	0.00276	0.0224	CbGeAlD
Epinastine—CYP2B6—female reproductive system—cervical cancer	0.00271	0.022	CbGeAlD
Epinastine—HRH1—female reproductive system—cervical cancer	0.00265	0.0215	CbGeAlD
Epinastine—HRH2—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0026	0.0789	CbGpPWpGaD
Epinastine—ADRA2A—female reproductive system—cervical cancer	0.0026	0.0211	CbGeAlD
Epinastine—CYP3A4—renal system—cervical cancer	0.00255	0.0208	CbGeAlD
Epinastine—CYP2D6—renal system—cervical cancer	0.00251	0.0204	CbGeAlD
Epinastine—CYP2B6—vagina—cervical cancer	0.00245	0.0199	CbGeAlD
Epinastine—HRH1—female gonad—cervical cancer	0.00241	0.0196	CbGeAlD
Epinastine—HRH1—vagina—cervical cancer	0.00239	0.0194	CbGeAlD
Epinastine—ADRA2A—female gonad—cervical cancer	0.00236	0.0192	CbGeAlD
Epinastine—ADRA2A—vagina—cervical cancer	0.00235	0.0191	CbGeAlD
Epinastine—HTR2A—female reproductive system—cervical cancer	0.00221	0.018	CbGeAlD
Epinastine—CYP3A4—female reproductive system—cervical cancer	0.00205	0.0166	CbGeAlD
Epinastine—CYP2D6—female reproductive system—cervical cancer	0.00201	0.0164	CbGeAlD
Epinastine—HTR2A—vagina—cervical cancer	0.002	0.0162	CbGeAlD
Epinastine—HTR7—Amine ligand-binding receptors—TAAR6—cervical cancer	0.00199	0.0604	CbGpPWpGaD
Epinastine—ABCB1—epithelium—cervical cancer	0.00195	0.0158	CbGeAlD
Epinastine—ABCB1—uterine cervix—cervical cancer	0.00193	0.0157	CbGeAlD
Epinastine—ABCB1—decidua—cervical cancer	0.00184	0.015	CbGeAlD
Epinastine—CYP2D6—female gonad—cervical cancer	0.00183	0.0149	CbGeAlD
Epinastine—ABCB1—renal system—cervical cancer	0.00181	0.0147	CbGeAlD
Epinastine—ABCB1—endometrium—cervical cancer	0.00175	0.0142	CbGeAlD
Epinastine—ABCB1—mammalian vulva—cervical cancer	0.00169	0.0137	CbGeAlD
Epinastine—ADRA2A—Platelet Aggregation (Plug Formation)—GP5—cervical cancer	0.00166	0.0504	CbGpPWpGaD
Epinastine—ABCB1—uterus—cervical cancer	0.00161	0.0131	CbGeAlD
Epinastine—HRH1—lymph node—cervical cancer	0.00155	0.0126	CbGeAlD
Epinastine—ADRA2A—lymph node—cervical cancer	0.00152	0.0124	CbGeAlD
Epinastine—ABCB1—female reproductive system—cervical cancer	0.00145	0.0118	CbGeAlD
Epinastine—ABCB1—female gonad—cervical cancer	0.00132	0.0107	CbGeAlD
Epinastine—ABCB1—vagina—cervical cancer	0.00131	0.0106	CbGeAlD
Epinastine—HTR2A—Amine ligand-binding receptors—TAAR6—cervical cancer	0.00128	0.0387	CbGpPWpGaD
Epinastine—HRH1—Amine ligand-binding receptors—TAAR6—cervical cancer	0.00127	0.0386	CbGpPWpGaD
Epinastine—ADRA1A—Amine ligand-binding receptors—TAAR6—cervical cancer	0.00125	0.0379	CbGpPWpGaD
Epinastine—HTR2A—Serotonin Receptor 2 and STAT3 Signaling—STAT3—cervical cancer	0.00122	0.0371	CbGpPWpGaD
Epinastine—ADRA2A—Amine ligand-binding receptors—TAAR6—cervical cancer	0.00116	0.0352	CbGpPWpGaD
Epinastine—HRH2—G alpha (s) signalling events—TAAR6—cervical cancer	0.00107	0.0326	CbGpPWpGaD
Epinastine—ABCB1—lymph node—cervical cancer	0.000847	0.00688	CbGeAlD
Epinastine—HTR7—G alpha (s) signalling events—TAAR6—cervical cancer	0.000823	0.0249	CbGpPWpGaD
Epinastine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000793	0.024	CbGpPWpGaD
Epinastine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000585	0.0177	CbGpPWpGaD
Epinastine—ADRA1A—G alpha (12/13) signalling events—AKAP13—cervical cancer	0.000528	0.016	CbGpPWpGaD
Epinastine—HRH2—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.000512	0.0155	CbGpPWpGaD
Epinastine—ADRA2A—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.000456	0.0138	CbGpPWpGaD
Epinastine—HTR7—Circadian rythm related genes—UBE3A—cervical cancer	0.00043	0.013	CbGpPWpGaD
Epinastine—ABCB1—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.000405	0.0123	CbGpPWpGaD
Epinastine—ADRA2A—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.000398	0.0121	CbGpPWpGaD
Epinastine—HTR7—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.000392	0.0119	CbGpPWpGaD
Epinastine—HRH2—GPCR ligand binding—TAAR6—cervical cancer	0.00039	0.0118	CbGpPWpGaD
Epinastine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00036	0.0109	CbGpPWpGaD
Epinastine—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	0.000347	0.0105	CbGpPWpGaD
Epinastine—HRH2—GPCR ligand binding—WNT2—cervical cancer	0.000304	0.00923	CbGpPWpGaD
Epinastine—HTR7—GPCR ligand binding—TAAR6—cervical cancer	0.000299	0.00905	CbGpPWpGaD
Epinastine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.000251	0.00761	CbGpPWpGaD
Epinastine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.000251	0.0076	CbGpPWpGaD
Epinastine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.000246	0.00745	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—SERPIND1—cervical cancer	0.000235	0.00712	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—GP6—cervical cancer	0.000235	0.00712	CbGpPWpGaD
Epinastine—HTR7—GPCR ligand binding—WNT2—cervical cancer	0.000233	0.00707	CbGpPWpGaD
Epinastine—HRH2—GPCR ligand binding—WNT5A—cervical cancer	0.000231	0.00699	CbGpPWpGaD
Epinastine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.000228	0.00693	CbGpPWpGaD
Epinastine—HRH2—GPCR downstream signaling—TAAR6—cervical cancer	0.00022	0.00668	CbGpPWpGaD
Epinastine—ABCB1—Allograft Rejection—HLA-DPB1—cervical cancer	0.000218	0.00661	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—GP5—cervical cancer	0.000205	0.00622	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—TAAR6—cervical cancer	0.0002	0.00606	CbGpPWpGaD
Epinastine—HTR2A—GPCR ligand binding—TAAR6—cervical cancer	0.000191	0.0058	CbGpPWpGaD
Epinastine—HRH1—GPCR ligand binding—TAAR6—cervical cancer	0.000191	0.00578	CbGpPWpGaD
Epinastine—ADRA1A—GPCR ligand binding—TAAR6—cervical cancer	0.000187	0.00568	CbGpPWpGaD
Epinastine—HTR7—GPCR ligand binding—WNT5A—cervical cancer	0.000177	0.00536	CbGpPWpGaD
Epinastine—ADRA2A—GPCR ligand binding—TAAR6—cervical cancer	0.000174	0.00527	CbGpPWpGaD
Epinastine—ABCB1—Allograft Rejection—HLA-DQB1—cervical cancer	0.00017	0.00516	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—TAAR6—cervical cancer	0.000169	0.00512	CbGpPWpGaD
Epinastine—ABCB1—HIF-1-alpha transcription factor network—TERT—cervical cancer	0.000164	0.00496	CbGpPWpGaD
Epinastine—ADRA1A—AMPK Signaling—MTOR—cervical cancer	0.000159	0.00481	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—WNT2—cervical cancer	0.000156	0.00473	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—TAAR6—cervical cancer	0.000153	0.00465	CbGpPWpGaD
Epinastine—HRH1—IL-4 Signaling Pathway—STAT3—cervical cancer	0.000152	0.00461	CbGpPWpGaD
Epinastine—HRH2—GPCR downstream signaling—AKAP13—cervical cancer	0.000151	0.00458	CbGpPWpGaD
Epinastine—HTR2A—GPCR ligand binding—WNT2—cervical cancer	0.000149	0.00453	CbGpPWpGaD
Epinastine—HTR2A—SIDS Susceptibility Pathways—HES1—cervical cancer	0.000149	0.00452	CbGpPWpGaD
Epinastine—HRH1—GPCR ligand binding—WNT2—cervical cancer	0.000149	0.00452	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000147	0.00446	CbGpPWpGaD
Epinastine—ADRA1A—GPCR ligand binding—WNT2—cervical cancer	0.000146	0.00443	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—AKAP13—cervical cancer	0.000137	0.00416	CbGpPWpGaD
Epinastine—ADRA2A—GPCR ligand binding—WNT2—cervical cancer	0.000136	0.00412	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—WNT2—cervical cancer	0.00012	0.00363	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—WNT5A—cervical cancer	0.000118	0.00359	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—TAAR6—cervical cancer	0.000118	0.00358	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—AKAP13—cervical cancer	0.000116	0.00351	CbGpPWpGaD
Epinastine—HTR2A—GPCR ligand binding—WNT5A—cervical cancer	0.000113	0.00343	CbGpPWpGaD
Epinastine—HRH1—GPCR ligand binding—WNT5A—cervical cancer	0.000113	0.00342	CbGpPWpGaD
Epinastine—ABCB1—Allograft Rejection—CASP8—cervical cancer	0.000111	0.00337	CbGpPWpGaD
Epinastine—ADRA1A—GPCR ligand binding—WNT5A—cervical cancer	0.000111	0.00336	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—TAAR6—cervical cancer	0.000108	0.00328	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—TAAR6—cervical cancer	0.000108	0.00327	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—TAAR6—cervical cancer	0.000106	0.00321	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—AKAP13—cervical cancer	0.000105	0.00318	CbGpPWpGaD
Epinastine—ADRA2A—GPCR ligand binding—WNT5A—cervical cancer	0.000103	0.00312	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—TAAR6—cervical cancer	9.83e-05	0.00298	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—TAAR6—cervical cancer	9.81e-05	0.00297	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—TAAR6—cervical cancer	9.79e-05	0.00297	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—TAAR6—cervical cancer	9.61e-05	0.00291	CbGpPWpGaD
Epinastine—ADRA1A—AMPK Signaling—TP53—cervical cancer	9.36e-05	0.00284	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—WNT2—cervical cancer	9.23e-05	0.0028	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—WNT5A—cervical cancer	9.07e-05	0.00275	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—TAAR6—cervical cancer	9.05e-05	0.00274	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—TAAR6—cervical cancer	8.93e-05	0.00271	CbGpPWpGaD
Epinastine—ABCB1—Allograft Rejection—CASP3—cervical cancer	8.42e-05	0.00255	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—AKAP13—cervical cancer	8.1e-05	0.00246	CbGpPWpGaD
Epinastine—HTR2A—SIDS Susceptibility Pathways—CASP3—cervical cancer	7.76e-05	0.00235	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—WNT2—cervical cancer	7.66e-05	0.00232	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—WNT2—cervical cancer	7.64e-05	0.00232	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—WNT2—cervical cancer	7.5e-05	0.00227	CbGpPWpGaD
Epinastine—HTR2A—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	7.48e-05	0.00227	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—AKAP13—cervical cancer	7.41e-05	0.00225	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—AKAP13—cervical cancer	7.39e-05	0.00224	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—AKAP13—cervical cancer	7.25e-05	0.0022	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—WNT2—cervical cancer	7.07e-05	0.00214	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—WNT5A—cervical cancer	6.99e-05	0.00212	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—WNT2—cervical cancer	6.97e-05	0.00211	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—AKAP13—cervical cancer	6.74e-05	0.00204	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—AKAP13—cervical cancer	6.72e-05	0.00204	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—AKAP13—cervical cancer	6.71e-05	0.00203	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—AKAP13—cervical cancer	6.58e-05	0.002	CbGpPWpGaD
Epinastine—HTR7—Circadian rythm related genes—TP53—cervical cancer	6.35e-05	0.00192	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—AKAP13—cervical cancer	6.21e-05	0.00188	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—AKAP13—cervical cancer	6.12e-05	0.00185	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—WNT5A—cervical cancer	5.8e-05	0.00176	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TAAR6—cervical cancer	5.8e-05	0.00176	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—WNT5A—cervical cancer	5.79e-05	0.00176	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TAAR6—cervical cancer	5.78e-05	0.00175	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—WNT5A—cervical cancer	5.68e-05	0.00172	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TAAR6—cervical cancer	5.68e-05	0.00172	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	5.49e-05	0.00166	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—WNT5A—cervical cancer	5.36e-05	0.00162	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—WNT5A—cervical cancer	5.28e-05	0.0016	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TAAR6—cervical cancer	5.27e-05	0.0016	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—NOTCH2—cervical cancer	4.91e-05	0.00149	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—CA9—cervical cancer	4.65e-05	0.00141	CbGpPWpGaD
Epinastine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	4.59e-05	0.00139	CbGpPWpGaD
Epinastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	4.58e-05	0.00139	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—WNT2—cervical cancer	4.52e-05	0.00137	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—WNT2—cervical cancer	4.52e-05	0.00137	CbGpPWpGaD
Epinastine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	4.49e-05	0.00136	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—WNT2—cervical cancer	4.43e-05	0.00134	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—CA9—cervical cancer	4.36e-05	0.00132	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	4.15e-05	0.00126	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—WNT2—cervical cancer	4.12e-05	0.00125	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—HES1—cervical cancer	4.02e-05	0.00122	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	4e-05	0.00121	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—AKAP13—cervical cancer	3.97e-05	0.0012	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—AKAP13—cervical cancer	3.96e-05	0.0012	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—AKAP13—cervical cancer	3.89e-05	0.00118	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—NOTCH2—cervical cancer	3.76e-05	0.00114	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—AKAP13—cervical cancer	3.61e-05	0.0011	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—TERT—cervical cancer	3.53e-05	0.00107	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—WNT5A—cervical cancer	3.43e-05	0.00104	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—WNT5A—cervical cancer	3.42e-05	0.00104	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—WNT5A—cervical cancer	3.36e-05	0.00102	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—FGFR3—cervical cancer	3.24e-05	0.000981	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—CA9—cervical cancer	3.21e-05	0.000975	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	3.17e-05	0.000962	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—WNT5A—cervical cancer	3.12e-05	0.000946	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—HES1—cervical cancer	3.08e-05	0.000934	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—NOTCH1—cervical cancer	3.04e-05	0.000921	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—CA9—cervical cancer	3.03e-05	0.000918	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—EGFR—cervical cancer	2.71e-05	0.00082	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—TERT—cervical cancer	2.7e-05	0.000819	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	2.66e-05	0.000807	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—FGFR3—cervical cancer	2.48e-05	0.000751	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	2.41e-05	0.00073	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—NOTCH2—cervical cancer	2.4e-05	0.000728	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—NOTCH2—cervical cancer	2.36e-05	0.000714	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—NOTCH1—cervical cancer	2.33e-05	0.000705	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—MTOR—cervical cancer	2.28e-05	0.00069	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—NOTCH2—cervical cancer	2.19e-05	0.000664	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—CASP3—cervical cancer	2.09e-05	0.000635	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—EGFR—cervical cancer	2.07e-05	0.000629	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—CTNNB1—cervical cancer	2.02e-05	0.000612	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CA9—cervical cancer	1.98e-05	0.0006	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—HES1—cervical cancer	1.97e-05	0.000598	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—HES1—cervical cancer	1.97e-05	0.000597	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—HES1—cervical cancer	1.93e-05	0.000586	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—MTHFR—cervical cancer	1.89e-05	0.000572	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—HES1—cervical cancer	1.8e-05	0.000544	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—MTHFR—cervical cancer	1.77e-05	0.000536	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—TP53—cervical cancer	1.77e-05	0.000536	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—STAT3—cervical cancer	1.76e-05	0.000533	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MTOR—cervical cancer	1.74e-05	0.000529	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TERT—cervical cancer	1.73e-05	0.000524	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TERT—cervical cancer	1.73e-05	0.000523	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TERT—cervical cancer	1.69e-05	0.000513	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CASP3—cervical cancer	1.6e-05	0.000486	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—EGFR—cervical cancer	1.6e-05	0.000485	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—FGFR3—cervical cancer	1.59e-05	0.000481	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—FGFR3—cervical cancer	1.58e-05	0.00048	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TERT—cervical cancer	1.57e-05	0.000477	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—FGFR3—cervical cancer	1.55e-05	0.000471	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CTNNB1—cervical cancer	1.55e-05	0.000469	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	1.49e-05	0.000452	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—NOTCH1—cervical cancer	1.49e-05	0.000451	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—NOTCH1—cervical cancer	1.46e-05	0.000442	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—FGFR3—cervical cancer	1.44e-05	0.000438	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—NOTCH1—cervical cancer	1.36e-05	0.000411	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—STAT3—cervical cancer	1.35e-05	0.000409	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—TP53—cervical cancer	1.34e-05	0.000407	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—EGFR—cervical cancer	1.33e-05	0.000402	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—EGFR—cervical cancer	1.32e-05	0.000402	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—MTHFR—cervical cancer	1.3e-05	0.000396	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—EGFR—cervical cancer	1.3e-05	0.000394	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—MTHFR—cervical cancer	1.23e-05	0.000373	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—EGFR—cervical cancer	1.22e-05	0.000371	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—EGFR—cervical cancer	1.21e-05	0.000366	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MTOR—cervical cancer	1.12e-05	0.000338	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MTOR—cervical cancer	1.11e-05	0.000338	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MTOR—cervical cancer	1.09e-05	0.000331	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—TP53—cervical cancer	1.03e-05	0.000312	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CASP3—cervical cancer	1.03e-05	0.000311	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CASP3—cervical cancer	1.02e-05	0.000311	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MTOR—cervical cancer	1.02e-05	0.000308	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CASP3—cervical cancer	1.01e-05	0.000305	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	9.9e-06	0.0003	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CTNNB1—cervical cancer	9.88e-06	0.000299	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CTNNB1—cervical cancer	9.69e-06	0.000294	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CASP3—cervical cancer	9.34e-06	0.000283	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CTNNB1—cervical cancer	9e-06	0.000273	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—STAT3—cervical cancer	8.63e-06	0.000262	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—STAT3—cervical cancer	8.61e-06	0.000261	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—STAT3—cervical cancer	8.45e-06	0.000256	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—MTHFR—cervical cancer	8.04e-06	0.000244	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—STAT3—cervical cancer	7.85e-06	0.000238	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—EGFR—cervical cancer	7.84e-06	0.000238	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—EGFR—cervical cancer	7.82e-06	0.000237	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—EGFR—cervical cancer	7.68e-06	0.000233	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—EGFR—cervical cancer	7.13e-06	0.000216	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TP53—cervical cancer	6.58e-06	0.0002	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TP53—cervical cancer	6.57e-06	0.000199	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TP53—cervical cancer	6.45e-06	0.000195	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TP53—cervical cancer	5.99e-06	0.000182	CbGpPWpGaD
